Nxera Pharma Co., Ltd. will hold an R&D Day on 6 November 2024 at 16:30 JST. The meeting will be held virtually via Zoom webinar. Please click here to pre-register for the event. Date: Wednesday ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

The company's stock price took a big hit in September after its R&D Day when it announced cuts to R&D funding and a pipeline shakeup. Adding to the misery, Moderna (NASDAQ:MRNA) was the most ...

Belgium has solidified its position as a European leader in pharmaceutical research and development with a daily investment ...

Reeves' budget promised investment for innovation and R&D with a view to "harnessing the full potential of the UK’s science ...

One of the three men on trial in a case where they are charged with carrying out a triple murder in Rivière-des-Prairies ...

Dr. Matt Barnes, Executive Officer, President of Nxera Pharma UK and Head of R&D Dr. Makoto Sugita, Executive Officer, Chief Medical Officer (CMO) and President of Nxera Pharma Japan Hironoshin ...

Virtual Investor & Analyst Cell Therapy R&D Day to be held on November 14 at 10 am. Webcast Link Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news.

Dr. Matt Barnes, Executive Officer, President of Nxera Pharma UK and Head of R&D Dr. Makoto Sugita, Executive Officer, Chief Medical Officer (CMO) and President of Nxera Pharma Japan Hironoshin Nomura ...

Presentation slides will be made available by 16:00 JST (7:00 GMT) on 6 November through the investor section of the Company's Home Page here. Nxera Pharma (formerly Sosei Heptares) is a technology ...

Nxera Pharma Co., Ltd. will hold an R&D Day on 6 November 2024 at 16:30 JST. The meeting will be held virtually via Zoom webinar. Please click here to pre-register for the event. Dr. Matt Barnes, ...